A
Anne Sandrine Blanc
Researcher at Novartis
Publications - 2
Citations - 97
Anne Sandrine Blanc is an academic researcher from Novartis. The author has contributed to research in topics: Internal medicine & Midostaurin. The author has an hindex of 1, co-authored 1 publications receiving 84 citations.
Papers
More filters
Journal ArticleDOI
Lower risk of infectious deaths in cardiac transplant patients receiving basiliximab versus anti-thymocyte globulin as induction therapy.
Marie Françoise Mattei,Michel Redonnet,Iradj Gandjbakhch,Annick Mouly Bandini,Allain Billes,Eric Epailly,Romain Guillemain,Bernard Lelong,Annie Pol,M. Treilhaud,Emmanuelle Vermes,Richard Dorent,Djamila Lemay,Anne Sandrine Blanc,Pascale Boissonnat +14 more
TL;DR: Basiliximab offers improved tolerability with similar efficacy compared with current polyclonal antibody induction therapy in de novo heart transplant patients, and this 6-month, prospective, randomized, multicenter, open-label study examined whether basiliximrab offers a tolerability benefit compared with anti-thymocyte globulin.
Journal ArticleDOI
Therapeutic management and outcome of patients with advanced systemic mastocytosis treated with midostaurin: A comprehensive real‐life study in the French national healthcare database
Julien Rossignol,Sandra Nizard,Anne Sandrine Blanc,Anne Filipovics,Joannie Lortet-Tieulent,Hassiba Bouktit,Gwendoline Poinsot,A Schmidt,Fanny Raguideau,Olivier Hermine +9 more
TL;DR: In this first real-life study on patients treated with midostaurin for Adv-SM, the patients' characteristics, their management, treatment discontinuation, and survival were in line with previous results (compassionate use and clinical trials).